antiviral drug
India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial
The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients
Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
Cipla to price remdesivir version for COVID-19 under Rs 5,000
Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.
Is a cure for HIV inching closer? Scientists discover new possibility
Team creates neutralising antibody, effective not only against all genetically divergent global HIV-1 strains, but also on latent cells.
1 of 1